© Copyright - Newspaper WordPress Theme by TagDiv
Carvedilol
Also known as / Synonyms: Carvedilol, Non-selective beta blocker with alpha-1 blocking activity
Non-selective beta and alpha-1 blocker improving survival in heart failure and reducing high blood pressure.
Clinical Snapshot & Specifications
Approved Indications & Medical Uses
- Mild to severe chronic heart failure of ischemic or cardiomyopathic origin (NYHA Class II-IV) as GDMT.
- Left ventricular dysfunction following acute myocardial infarction (LVEF <= 40%).
- Essential hypertension (alone or with other antihypertensives).
Contraindications (Do Not Use If…)
- Severe chronic heart failure requiring IV inotropic therapy.
- Bronchial asthma or severe chronic obstructive pulmonary disease (COPD) with bronchospasm.
- Second- or third-degree AV block (unless pacemaker placed).
- Severe bradycardia (< 50 bpm) or sick sinus syndrome.
- Cardiogenic shock or severe hypotension (systolic BP < 85 mmHg).
- Severe hepatic impairment.
Important Clinical Precautions & Warnings
- Do not discontinue abruptly; abrupt cessation can cause acute exacerbation of angina, myocardial infarction, or ventricular arrhythmias.
- Postural hypotension and dizziness: start low, titrate slowly every 2 weeks, and administer with food.
- Worsening heart failure or fluid retention: monitor daily weights during titration; adjust diuretic doses.
- Masks hypoglycemia signs: suppresses tachycardia in diabetic patients; tremors and diaphoresis may persist.
- Peripheral vascular disease: may aggravate symptoms of arterial insufficiency.
Special Populations (Paediatric & Geriatric Care)
Pediatric: Safety and efficacy in children < 18 years have not been established. Elderly: Heightened sensitivity to postural hypotension and bradycardia; monitor blood pressure and pulse.
Side Effects & Adverse Reactions
Common Side Effects (Usually Mild)
Dizziness, fatigue, hypotension, bradycardia, fluid overload/peripheral edema, weight gain, diarrhea, and hyperglycemia in diabetics.
Serious Side Effects — Seek Urgent Medical Care
Severe bradycardia, complete heart block, acute cardiogenic shock, bronchospasm in susceptible patients, and severe syncope.
Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.
Drug, Food & Substance Interactions
- Calcium channel blockers (verapamil, diltiazem): profound bradycardia and conduction abnormalities.
- Digoxin: increased digoxin plasma levels and enhanced AV nodal slowing.
- Insulin and oral antidiabetics: potentiates hypoglycemia and masks autonomic symptoms.
- CYP2D6 inhibitors (fluoxetine, paroxetine): increased carvedilol blood concentrations.
- Clonidine: concurrent discontinuation can cause severe rebound hypertension.
Pregnancy & Lactation Clinical Safety
Pregnancy Safety:
Use with caution — see notesBeta-blockers can cause decreased placental perfusion, intrauterine growth restriction, neonatal bradycardia, and hypoglycemia. Use only if clearly required.
Lactation & Breastfeeding:
Use with caution — see notesExcretion in human milk is likely; monitor infant for bradycardia and hypotension or consider alternative therapy.
Storage, Administration & Overdose Protocol
🌡️ Recommended Storage:
Store below 30°C in moisture-proof packaging. Protect from direct sunlight.
⏱️ Missed Dose Protocol:
Take twice daily with food to slow absorption and reduce orthostatic dizziness. If missed, take as soon as remembered unless within 4 hours of next dose.
Overdose causes severe bradycardia, profound hypotension, heart failure, cardiogenic shock, and cardiac arrest. Immediate emergency treatment with IV glucagon, atropine, and inotropes is critical.
Clinical Sources & Regulatory References
Statutory drug monograph citations and regulatory databases consulted for clinical synthesis.
Every clinical monograph on 4mg.in is continuously cross-referenced against official pharmacopoeias, national formulary compendia, and statutory regulatory filings to guarantee therapeutic precision:
Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Evaluated for approved indications, Schedule H/H1 status, and National List of Essential Medicines (NLEM).
CDSCO Official Portal →U.S. Food and Drug Administration Approved Prescribing Information, Package Inserts, and Pharmacovigilance Black Box Warnings repository via NLM DailyMed.
Search FDA Labels on DailyMed →WHO Model List of Essential Medicines (23rd List) and WHO Collaborating Centre for Drug Statistics Methodology (Anatomical Therapeutic Chemical - ATC / DDD Index).
WHO Essential Medicines Registry →National Center for Biotechnology Information (NCBI). Peer-reviewed clinical trials, bioavailability investigations, and Cochrane systematic reviews.
Query PubMed Studies for Carvedilol →
4mg Clinical Pharmacology Team. Carvedilol Monograph: Uses, Dosage, Contraindications & Interactions. Medically reviewed by licensed clinical editors. 4mg.in, 2026. Available at: https://4mg.in/medicines/carvedilol/
